TEST BANK FOR PHARMACOLOGY A PATIENTCENTERED NURSING PROCESS APPROACH (9TH EDITION, 2023/2024) ISBN PHARMACOLOGY 9TH EDITION MCCUISTION

Table of Contents Table of Contents Chapter 28: Peptides, Antimalarial, and Chapter 01: Drug Development and Ethical Considerations Chapter 02: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics Chapter 03: Cultural Considerations Chapter 04: Complementary and Alternative Therapies Chapter 05: Pediatric Considerations Chapter 06: Geriatric Considerations Chapter 07: Drugs in Substance Use Disorder Chapter 08: The Nursing Process and Patient-Centered Care Chapter 09: Safety and Quality Chapter 10: Drug Administration Chapter 11: Drug Calculations Chapter 12: Fluid Volume and Electrolytes Chapter 13: Vitamin and Mineral Replacement Chapter 14: Nutritional Support Chapter 15: Adrenergic Agonists and Antagonists Chapter 16: Cholinergic Agonists and Antagonists Chapter 17: Stimulants Chapter 18: Depressants Chapter 19: Antiseizure Drugs Chapter 20: Drugs for Parkinsonism and Alzheimer's Disease Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms Chapter 22: Antipsychotics and Anxiolytics Chapter 23: Antidepressants and Mood Stabilizers Chapter 24: Antiinflammatories Chapter 25: Analgesics Chapter 26: Antibacterials Chapter 27: Antituberculars, Antifungals, and Antivirals Anthelmintic Chapter 29: HIV- and AIDS-Related Drugs Chapter 30: Transplant Drugs Chapter 31: Vaccines Chapter 32: Anticancer Drugs Chapter 33: Targeted Therapies to Treat Cancer Chapter 34: Biologic Response Modifiers Chapter 35: Upper Respiratory Disorders Chapter 36: Lower Respiratory Disorders Chapter 37: Cardiac Glycosides, Antianginals, and Antidysrhythmics Chapter 38: Diuretics Chapter 39: Antihypertensive Chapter 40: Anticoagulants, Antiplatelets, and Thrombolytics Chapter 41: Antihyperlipidemics and Peripheral Vasodilators Chapter 42: Gastrointestinal Tract Disorders Chapter 43: Antiulcer Drugs Chapter 44: Eye and Ear Disorders Chapter 45: Dermatologic Disorders Chapter 46: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders Chapter 47: Antidiabetics Chapter 48: Urinary Disorders Chapter 49: Pregnancy and Preterm Labor Chapter 50: Labor, Delivery, and Postpartum Chapter 51: Neonatal and Newborn Chapter 52: Women's Reproductive Health Chapter 53: Men's Reproductive Health Chapter 54: Sexually Transmitted Infections Chapter 55: Adult and Pediatric Emergency Drugs Chapter 01: Drug Development and Ethical Considerations MULTIPLE CHOICE 1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of the contents of a Single-use vial. Which nursing action is correct? a. Ask another nurse to observe and cosign wasting the remaining drug from the vial. b. Keep the remaining amount in the patient’s drawer to give at the next dose. c. Record the amount unused in the patient’s medication record. d. Dispose of the vial with the remaining drug into a locked collection box. ANS: A Schedule II drugs are controlled substances, and all must be accounted for. When wasting a portion of a drug, another nurse should observe and cosign that a drug was wasted. DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Nursing Intervention MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic form. The nurse understands that a generic medication will have a name that a. is a registered trademark. b. is always capitalized. c. describes the drugs chemical structure. d. is non-proprietary. ANS: D The generic name is the official, non-proprietary name for a drug. The brand name is the trademark name and is always capitalized. The chemical name describes the chemical structure of the drug. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 3. A patient receives a prescription on which the provider has noted that a generic medication may be given.The patient asks the nurse what this means. What will the nurse tell the patientabout generic drugs? a. They contain the same inert ingredients as brand-name drugs. b. They have chemical structures that are identical to proprietary drugs. c. They tend to be less expensive than brand-name drugs. d. They undergo extensive testing before they are marketed. ANS: C Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brandname drug. They tend to be less expensive because manufacturers of these drugs do not have to do the extensive testing required of brand-name drugs before marketing. They are not identical to brand-name drugs and often have different inert ingredients. DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching MSC: NCLEX: Management of Client Care 4. The nurse reviews information about a drug and notes the initials USP after the drugs official name. The nurse understands that this designation indicates the drug a. is a controlled substance. b. is approved by the U.S. Food and Drug Administration (FDA). c. is available in generic form. d. meets quality and safety standards. ANS: D The USP designation is given to drugs that have met high standards for therapeutic use, patient safety, quality, purity, strength, packaging safety, and dosage form by the United States Pharmacopoeia National Formulary. The FDA classifies controlled substances with Roman numerals from I to V. The USP designation does not indicate FDA approval. The USP designation does not indicate generic availability. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 5. The nurse is preparing to give a medication to a child. The child’s parent asks whether the drug is safe for children. How will the nurse respond to the parent? a. Drugs are tested on adults and safe doses for children are based on weights compared to adult weights. b. Drugs are deemed safe for children over time when repeated use proves effectiveness and safety. c. Drugs are tested for both efficacy and safety in children in order to be marketed for pediatric use. d. Drugs are tested on children in post marketing studies and on a limited basis. ANS: C The Pediatric Research Equity Act requires drug manufacturers to test drugs on children. DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Nursing Intervention MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 6. Which law(s) govern all drug administration by nurses? a. Drug Regulation and Reform Act b. FDA Amendments Act c. Nurse Practice Acts d. The Controlled Substances Act ANS: C Each states Nurse Practice Act identifies how nurses administer medications. The other acts govern how drugs are marketed and tested. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 7. The nurse administers a drug and miscalculates the dose by placing the decimal place one space to the right, resulting in a 10-fold overdose and the death of the patient. What offense does this represent? a. Malfeasance b. Malpractice c. Misfeasance d. Nonfeasance ANS: C Misfeasance is negligence in giving either the wrong drug or the wrong dose, resulting in the death of the patient. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 8. The nurse is busy and neglects to give a drug to a patient resulting in the patient’s death. What offense does this represent? a. Malfeasance b. Malpractice c. Misfeasance d. Nonfeasance ANS: D Nonfeasance is omitting a drug dose, resulting in the patient’s death. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 9. A patient is taking methadone as part of a heroin withdrawal program. The nurse understands that, in this instance, methadone is classified as which drug schedule? a. C-I b. C-II c. C-III d. C-V ANS: B Methadone is a category II drug, with a high potential for drug abuse. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 10. The nurse is preparing to administer a combination drug containing acetaminophen and codeine. The nurse knows that this drug is classified as which drug schedule? a. C-II b. C-III c. C-IV d. C-V ANS: B Codeine is normally a category II drug, except when it is part of a combination product such as with acetaminophen, making it a category III drug. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 11. The nurse is obtaining consent from a subject newly recruited for a clinical drug trial that will last for 6 months. All subjects will be given gift certificates for participating. One subject says, Well, I guess if the drug doesn't work, I'll just have to put up with the symptoms for 6 months. What will the nurse tell the subject? a. Participation for the duration of the study is required. b. Participation may end at any time without penalty. c. Withdrawal from the study may end at any time, but the gift certificate will not be given. d. You can request placement in the treatment group. ANS: B All participants have the right to autonomy, which is the right to self-determination. Patients have the right to refuse to participate or to withdraw from a study at any time without penalty. Patients generally are not allowed to choose participation in either the treatment or the control group. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: Nursing Intervention MSC: NCLEX: Management of Client Care 12. The nurse is assisting with a clinical drug trial in which the side effects of two effective drugs are being compared. A patient who would benefit from either drug has elected to withdraw from the study, and the nurse assists with the paperwork to facilitate this. This is an example of a. autonomy. b. beneficence. c. justice. d. veracity. ANS: A All participants have the right to autonomy, which is the right to self-determination. Patients have the right to refuse to participate or to withdraw from a study at any time without penalty even if the health care provider disagrees with that choice. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 13. During a clinical drug trial for a new medication, researchers note a previously unknown serious adverse effect occurring in more than 50% of subjects. The study is discontinued. Which ethical principle is being exercised? a. Beneficence b. Justice c. Respect for persons d. Veracity ANS: A Beneficence is the duty to do well and to not harm others. Once a serious adverse effect is noted in a majority of subjects, researchers have an ethical obligation to stop the study. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 14. In a 5-year experimental clinical trial to investigate a new cancer treatment, researchers in the second year note overwhelming improvement in almost all of the subjects in the treatment group. The lead researcher elects to continue the study. Which ethical principle is being violated? a. Beneficence b. Justice c. Respect for persons d. Veracity ANS: B The principle of justice requires that all people be treated fairly, including equal access to health care for all. Once a benefit is demonstrated, it should be available to all participants. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 15. The nurse is enrolling subjects for a double-blind experimental study. One patient asks the nurse to explain the role of the experimental group. The nurse will explain that subjects in the experimental group in this type of study a. are selected for participation in that group. b. have unique baseline characteristics. c. receive a placebo. d. receive the treatment being evaluated. ANS: D In a double-blind experimental study, subjects in the experimental group receive the treatment or drug under study. They are randomly assigned and not selected. They should have similar baseline characteristics to those in the control group. They do not receive a placebo. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching MSC: NCLEX: Management of Client Care 16. The nurse is obtaining signatures on consent forms for participation in a clinical drug trial. One patient says, “I’m not sure I want to do this, but I need the cash”. The nurse will take which action? a. Ask the patient to clarify concerns. b. Reinforce that cash is given to all subjects equally. c. Report this statement to the party named on the consent. d. Review the elements of the study and obtain consent. ANS: C If a nurse suspects that a patient is being coerced to participate in the study, the nurse should report this to the party named on the informed consent. When a patient verbalizes participation based on a financial reward, there is an element of coercion. DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Nursing Intervention MSC: NCLEX: Management of Client Care 17. Which is characteristic of preclinical in vivo testing? a. A comparison of experimental and control data in animals b. A study conducted in a test tube in a laboratory c. A study that determines the parameters of safe therapeutic doses d. A study to assess the seriousness of the disease to be treated ANS: A Preclinical in vivo testing is performed in animals or other living organisms. In vitro studies occur in test tubes. Safe therapeutic dose studies are part of clinical research. Prior to clinical trials, an assessment is made of the disease and its seriousness. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 18. Many drugs marketed in the 1980s may not be effective in a majority of the population. The nurse understands that this is because these drugs a. did not pass through the appropriate phases of clinical trials. b. did not require human subject protections and are invalid. c. were not tested on women, minorities, or children. d. were tested on healthy subjects only. ANS: C Drug research was historically done only with white males, causing uncertainty as to the validity of the research results. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 19. The nurse is assisting with data collection in a study of drug effects in healthy subjects. The nurse assists with blood and urine collection to determine serum drug levels and the presence of metabolites in the urine. Which phase of a drug study does this represent? a. Phase I b. Phase II c. Phase III d. Phase IV ANS: A Phase I drug trials are performed to assess safety and to identify the pharmacokinetics, such as metabolism and elimination, of drugs in healthy subjects. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 20. The nurse is enrolling subjects for a clinical drug trial in which subjects will be randomly assigned to either a treatment or a placebo group. The pills in both groups will be in identical packaging with identical appearance. This is an example of which type of study? a. Crossover b. Double-blind c. Open-label d. Single-blind ANS: B In a double-blind study, neither the subject nor the health care provider knows which group the subjects are in. Since there is no difference in the appearance or packaging of the pills, the health care providers will not be aware of which subjects receive the experimental drug and which ones receive the placebo. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 21. The nurse is assisting with a clinical drug trial to test the safe dose of an analgesic medication and learns that subjects have been told that the study is about measuring the analgesic effects. Which ethical principle has been violated? a. Beneficence b. Justice c. Respect for persons d. Veracity ANS: D Veracity requires health care professionals to tell the truth. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 22. The nurse is participating in a clinical study of the effects of teaching on drug compliance. The subjects are randomly assigned to either an experimental group or a control group. Health professionals deliver one of two teaching modules to each patient. This is an example of which kind of study? a. Double-blind b. Open-label c. Single-blind d. Triple-blind ANS: C In a single-blind study, only the subjects do not know which group they are assigned to. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 23. A clinical drug trial is concluding a study of pharmacokinetics and safety of a drug in healthy individuals. The nurse will assist enrollment of participants into the next phase of the study and will include which subjects? a. Healthy subjects b. Healthy and ill subjects c. Subjects with the disease the drug will treat d. Subjects with other diseases ANS: C After Phase I studies demonstrating drug safety and pharmacokinetics have been completed, the drug is tested on subjects who have the disease the drug will treat. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: Nursing Intervention MSC: NCLEX: Management of Client Care 24. Before marketing a new drug that has been approved for use based on clinical effectiveness and safety, the manufacturer wishes to study the potential new uses for the drug. This is an example of which phase of study? a. Phase I b. Phase II c. Phase III d. Phase IV ANS: D Phase IV studies are performed to examine potential new indications for approved drugs. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Management of Client Care 25. The nurse is participating in a clinical drug trial comparing two drugs for migraine headaches. Each group is randomly assigned to either drug A or drug B and then switched to the other drug group before being asked to compare the effects. This is an example of which type of study? a. Crossover design b. Double-blind experimental design c. Matched pair design d. Quasi-experimental design ANS: A A crossover design uses each subject in several different situations. In this case, subjects receive both drugs and then compare the effects